Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional Study Evaluating Samples From Patients With Suspected Non-small Lung Cancer or Breast Cancer to Describe Pathology Practices and to Evaluate Computational Pathology Plus Artificial Intelligence Algorithms.

NCT06827132 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06827132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06827132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional Study Evaluating Samples From Patients With Suspected Non-small Lung Cancer or Breast Cancer to Describe Pathology Practices and to Evaluate Computational Pathology Plus Artificial Intelligence Algorithms.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 25, 2025
Completion date
March 19, 2026
Enrollment
603 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lung cancer